Episode
Choosing the Right Microdose: Psilocybin, LSD, Huachuma & More - Paul F. Austin
- Podcast
- The Psychedelic Podcast
- Published
- Jun 8, 2026
- Duration seconds
- 2781
- Processing state
not_requested- Canonical source
- https://thethirdwave.co/podcast/episode-359/?ref=278
Actions
POST https://stenobird.com/v1/public/podcasts/the-psychedelic-podcast-221919/episodes/choosing-the-right-microdose-psilocybin-lsd-huachuma-more-paul-f-austin/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/the-psychedelic-podcast-221919/choosing-the-right-microdose-psilocybin-lsd-huachuma-more-paul-f-austin.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
In this special solo episode, adapted from a recent live training, Paul F. Austin explores one of the most important and often overlooked realities of microdosing: different substances create different outcomes. Find full show notes and links here: https://thethirdwave.co/podcast/episode-359/?ref=278 Drawing on more than a decade of experience in psychedelic education and coaching, Paul compares psilocybin, LSD, huachuma (San Pedro), ketamine, and iboga through the lens of client goals, nervous system regulation, emotional processing, cognitive performance, and contraindications. Paul explains why generic microdosing protocols often fall short, how practitioners can better match substances to individual needs, and why context, preparation, and integration matter far more than any single medicine. He also shares why huachuma has become the foundation of the Psychedelic Coaching Institute's microdosing methodology and offers guidance for practitioners looking to support clients with greater precision and care. Highlights: Why generic microdosing protocols can fall short How psilocybin supports emotional processing and inner work LSD's role in focus, creativity, and physiological performance Why huachuma may be especially useful for nervous system regulation Ketamine's role in SSRI tapering and clinical support Iboga's potential for neurodegenerative conditions and brain injury How to match substances to a client's goals and baseline state Why contraindications and clinical-grade intake matter How microdosing can support post-journey integration Why "more medicine" is not always the answer Episode Links: Paul on Instagram The Psychedelic Podcast The Psychedelic Coaching Institute Episode Sponsors: The Practitioner Certification Program by Third Wave's Psychedelic Coaching…